Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study
利索卡巴他根马拉鲁塞与二线复发/难治性大B细胞淋巴瘤标准治疗方案对比:来自随机III期TRANSFORM研究的3年随访结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00399
Kamdar, Manali; Solomon, Scott R; Arnason, Jon; Johnston, Patrick B; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Chow, Victor A; Montheard, Sandrine; Santamaria, Josu; Colicino, Silvia; Ogasawara, Ken; Stepan, Lara; Liu, Fei Fei; Abramson, Jeremy S